Calithera Biosciences, Inc. announced that the company's board of directors has appointed Dr. Sunil Agarwal, M.D., Chief Medical Officer and Senior Vice President at Ultragenyx Pharmaceutical Inc., as an independent director. Agarwal is currently Senior Vice President and Chief Medical Officer at Ultragenyx where he is responsible for the company's clinical development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | 0.00% | 0.00% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 97.45T | |
+39.82% | 73TCr | |
+32.47% | 59TCr | |
-7.31% | 35TCr | |
+14.23% | 32TCr | |
+0.86% | 28TCr | |
+13.92% | 24TCr | |
-6.50% | 20TCr | |
+8.26% | 21TCr | |
+4.51% | 16TCr |
- Stock Market
- Equities
- CALA Stock
- News Calithera Biosciences, Inc.
- Calithera Biosciences, Inc. Appoints Sunil Agarwal as Independent Director